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Abstract
Experimentally renal tissue hypoxia appears to play an important role in the pathogenesis of chronic kidney disease (CKD)
and arterial hypertension (AHT). In this study we measured renal tissue oxygenation and its determinants in humans using
blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) under standardized hydration conditions.
Four coronal slices were selected, and a multi gradient echo sequence was used to acquire T2* weighted images. The mean
cortical and medullary R2* values ( = 1/T2*) were calculated before and after administration of IV furosemide, a low R2*
indicating a high tissue oxygenation. We studied 195 subjects (95 CKD, 58 treated AHT, and 42 healthy controls). Mean
cortical R2 and medullary R2* were not significantly different between the groups at baseline. In stimulated conditions
(furosemide injection), the decrease in R2* was significantly blunted in patients with CKD and AHT. In multivariate linear
regression analyses, neither cortical nor medullary R2* were associated with eGFR or blood pressure, but cortical R2*
correlated positively with male gender, blood glucose and uric acid levels. In conclusion, our data show that kidney
oxygenation is tightly regulated in CKD and hypertensive patients at rest. However, the metabolic response to acute
changes in sodium transport is altered in CKD and in AHT, despite preserved renal function in the latter group. This suggests
the presence of early renal metabolic alterations in hypertension. The correlations between cortical R2* values, male gender,
glycemia and uric acid levels suggest that these factors interfere with the regulation of renal tissue oxygenation.
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Introduction
Numerous experimental studies have suggested that disturbed
oxygenation plays a role in the development and progression of
kidney disease including hypertensive nephropathy[1–3].Thus,
using micro-electrodes for direct pO2 measurements, low cortical
O2 levels have been found in spontaneous hypertensive rats and in
rats with streptozotocine-induced diabetes or in the subtotal
nephrectomy model [4,5].
Until recently, human data were largely lacking mainly due to
the lack of non-invasive methods to estimate renal tissue
oxygenation. Over the last decade, blood oxygenation level-
dependent magnetic resonance imaging (BOLD-MRI) has become
a powerful tool to estimate renal tissue oxygenation non-invasively
in humans. The basic principle of BOLD-MRI is that changes in
renal tissue desoxyhemoglobin concentrations involve generation
of phase incoherence of magnetic spins, leading to an increase in
apparent relaxation rate R2* (expressed in sec21). Under the
assumption that blood pO2 is in equilibrium with tissue pO2, R2*
values provide estimates of tissue oxygenation, a low R2*
indicating a high tissue oxygenation [6]. Using post-processing
programs, several circles - called regions of interest (ROI’s) - are
placed manually per slice in the cortex and in the medulla. This
allows the assessment of the average cortical and medullary R2*
value, per kidney or for both kidneys together, without the need to
administer contrast product [7].
Several studies have used BOLD-MRI in humans to investigate
renal oxygenation in different forms of chronic kidney disease
(CKD) [8,9]. The largest study which assessed renal oxygenation
at different degrees of kidney dysfunction was published by
Michaely et al and included 400 patients [10]. Interestingly, no
correlation was found between cortical and medullary R2* values
and the estimated glomerular filtration rate (eGFR, according to
the MDRD-formula) in this study. However this evaluation had
several limitations: renal function was not measured in all patients
(280 with measured creatinine levels), no information was collected
on medication intake or baseline characteristics such as blood
pressure or underlying renal disease, and BOLD-MRI was not
performed under standardized conditions of fluid and sodium
intake which are known to have a strong influence on renal
oxygenation measured by BOLD-MRI [11,12].
Changes in renal tissue oxygenation may also contribute to the
development of ischemic and hypertensive nephropathies [5]. For
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these reasons, most studies performed in hypertensive patients so
far have been conducted in patients with renal artery stenosis
[13,14]. Other studies in patients with essential hypertension have
focused on the role of sodium, angiotensin II or race on cortical
and medullary oxygenation [12,15,16]. These studies were
performed in a relatively small number of participants, or did
not include a control group. Whether or not essential hypertension
is characterized by chronic hypoxia in humans remains therefore
an open question.
The aim of the present study was therefore to assess renal tissue
oxygenation at baseline and after an acute administration of
furosemide in patients with various levels of renal function as well
as in patients with essential hypertension and a normal renal
function and in control subjects. Moreover, we analyzed the
potential determinants of renal cortical and medullary tissue
oxygenation in these patient groups.
Methods
This research project was approved by the local institutional
review committee (Ethical Committee of the Canton de Vaud,
Switzerland) and conducted according to the principles expressed
in the Declaration of Helsinki. Written informed consent was
obtained from each participant.
Subjects
Patients with CKD stage 1–5, or with hypertension without
CKD were eligible for this study. CKD was defined as an
estimated glomerular filtration rate (eGFR) #60 ml/min/
1.73 m2, or the presence of structural or functional abnormalities
for at least three months [17]. Arterial hypertension (AHT) was
defined as mean office blood pressure (BP) $140/90 mmHg
measured at more than one occasion, or an office BP ,140/
90 mmHg while taking one or more antihypertensive drugs. Other
inclusion criteria were: age $18 years and the ability to
understand the study protocol and to sign an informed consent.
Controls were normotensive, untreated healthy individuals with-
out a history of kidney disease or hypertension or any other
concomitant disease. Exclusion criteria for all participants were: a
contra-indication to MR-imaging such as claustrophobia or the
presence of a pacemaker or other implanted metallic device.
Study protocol
Patients were recruited at the outpatient nephrology and
hypertension clinic of the university hospital in Lausanne (CHUV).
Controls were recruited by local advertisement. Participants were
maintained on their regular diet. Salt intake, proteinuria, and
creatinine clearance were measured before BOLD-MRI by a 24 h
urine collection. On the day of each BOLD-MRI measurement,
an identical oral hydration protocol was followed by each
participant at home (loading dose of 5 ml/kg of water at 8am,
followed by 3 ml/kg every hour till 12am), see extended methods
for further details and justification of this hydration protocol.
Subjects joined our research unit at 11.30 am. BP was measured
three times by an experienced research nurse using an automated
Omron 705IT oscillometric device according to the recommen-
dations of the European Society of Hypertension [18]. Periphe-
rical oxygen saturation was measured using a fingertip pulse
oxymeter (Oxy, Medair AB, Delsbo Sweden), and blood was
drawn by a catheter inserted into an antecubital vein.
BOLD-MRI
BOLD-MRI was performed between 1 and 2 pm in the
radiology department. Magnetic resonance measurements were
carried out on a 3T whole-body MR system (MAGNETOM Trio,
Siemens Medical Systems, Erlangen, Germany), as described
previously [12,19,20]. Briefly, four coronal slices with good
cortico-medullary differentiation obtained in expiration were
selected from morphological images for functional evaluation with
BOLD-MRI. Twelve T2*-weighted images were recorded within a
single breath-hold of 12.4 seconds with a modified Multi Echo
Data Image Combination sequence (MEDIC) with the following
parameters: repetition time (TR) 68 ms, echo time (TE) 6–52.2 ms
(equidistant echo time spacing 4.2 ms), flip angle 20u, field of view
(FOV) 4006400 mm2, voxel size 1.661.665 mm3, bandwidth
700 Hz/pixel, matrix 2566256 (interpolation to 5126512). All
images were exported for analysis with a home-built IDL program
(Interactive Data Language, Boulder, CO, USA). R2* maps were
calculated voxel by voxel using a Levenberg-Marquardt least-
squares algorithm to fit an exponential function to the signal
intensities measured for each echo time. ROIs were traced in the
form of circles of equal size (containing approximately 20 voxels
each) in the medulla and the cortex (two in the cortex and two in
the medulla in each kidney), as illustrated in Figure 1. The
reported R2* value was the mean value of four slices (16 ROIs) for
the medulla and the cortex. This technique has been shown to
have a good reproducibility [7,20]. Medullary-cortical R2*ratio
(MCR2*), as a marker of metabolic workload, was calculated for
each participant by dividing the mean medullary R2* by cortical
R2* levels [21]. The procedure was repeated for all four coronal
series obtained fifteen minutes after the administration of 20 mg
furosemide intravenously.
Statistics
Clinical data were analyzed using STATA 11.0 (StataCorp,
College Station, Texas, USA). Quantitative variables were
expressed as mean 6 standard deviation, or as median (25th–
75th percentile range), as appropriate. Qualitative variables were
expressed as number of patients and percentage. Comparisons
between baseline characteristics of study groups were analyzed
with ANOVA. Distribution of variables was also expressed using
the probability density function according to Kernel. In case of
non-normal distribution, variables were log-transformed. Multi-
variable logistic regression, adjusting for the predefined variables
age, sex, current smoking, body mass index, diabetes, hemoglobin,
and 24 h urinary sodium excretion, was used to determine the
independent association of cortical and medullary R2* values with
CKD status. These variables were selected based on their known
association with CKD (body mass index, diabetes, age), or because
of a theoretical association with renal tissue oxygenation (hemo-
globin, 24 h urinary sodium excretion, smoking).
Similarly, in order to determine the independent association of
each independent variable of interest with the dependent variables
cortical and medullary R2* values, multivariate linear regression
was performed, adjusted for the same predefined covariates.
Associations between the eGFR slope and R2* values were
examined with Spearman’s rank correlation and multivariable
linear regression analysis. Results of the logistic multivariate
analysis are presented as Odds-ratio (OR) and 95% confidence
interval (95% CI). Results of all linear multivariate analyses are
presented as beta-coefficients (b) and their 95% confidence
intervals. P values were derived from maximum likelihood ratio
tests. Statistical significance was considered for a two-sided P,
0.05.
Renal Tissue Oxygenation in CKD and Hypertension
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Results
Clinical characteristics of the patients and controls
Details of the screening procedure are provided in the ’extended
Methods and Results S1’ section. Baseline clinical characteristics
of patients with CKD and hypertension and of controls are shown
in Table 1. Patients in the CKD-and hypertensive group were
well-matched for age, sex and other baseline characteristics.
Healthy volunteers were significantly younger, and more often
female. Medical treatments of subjects according to group are
shown in Table 2 and across different stages of CKD in Table S1.
R2* levels in hypertension and CKD as compared with
healthy controls
There were no differences in mean or median cortical and
medullary R2* levels between the right and left kidney in all
groups (cortex (median (range)) respectively 17.4 (16.1; 18.6) and
17.6 (16.3; 18.8) sec21, p = 0.29; and medulla (mean6SD):
28.764.2 vs 28.762.5 sec21, p = 0.94). Therefore, only the mean
cortical and medullary R2* values of both kidneys are shown and
used for statistical analysis. The distribution of medullary R2* was
comparable in all groups, but that of cortical R2* values differed
markedly between groups (Figure 2A and B). A bimodal cortical
distribution was observed in controls and AHT patients, yet not in
CKD patients (Figure 2B). The bimodality of the probability
density function of cortical R2* values was partly explained by
gender (Figure 3); no gender-differences were seen in the
distribution of medullary R2* values (Figure S1). The mean
medullary and cortical R2* values and medullary-cortical ratio’s of
each group were comparable between the CKD, hypertensive and
control group (Table 3). No differences were seen in cortical and
Figure 1. Illustration of BOLD image analysis. Anatomical templates are shown on the left, R2* maps in the middle, and color maps on the right
(low R2* levels corresponding to higher tissue oxygenation in red, high R2* levels in yellow). Two regions of interest (ROIs) are traced in the form of
circles (20 voxels each) in the cortex and medulla of each kidney; this procedure is repeated on four different slices.
doi:10.1371/journal.pone.0095895.g001
Table 1. Baseline characteristics of patients and controls enrolled in the study.
Control (n = 42) CKD (n=95) AHT (n=58)
Age (years) 46613* 56615 57611
Sex (% female) 52* 30 32
Currently smoking (%) 7* 27 35
Body Mass Index (kg/m2) 2665 2765 2965
Systolic BP (mmHg) 122613* 135619 142616**
Diastolic BP (mmHg) 73610 76612 82610**
eGFR (CKD-EPI, ml/min/1.73 m2) 97614* 57631 91615**
eGFR (MDRD, ml/min/1.73 m2) 94615* 57629 91616**
Hemoglobin (g/dl) 136611 130618 138613**
Blood glucose (mmol/l) 5.660.9* 6.562.1 6.161.2
Diabetes (%) 0* 23 17
Blood potassium (mmol/l) 3.960.2* 4.260.6 3.860.3**
Venous bicarbonate (mmol/l) 27(20;30)* 25 (14;32) 27 (23;32)**
Blood uric acid (mmol/l) 289 (130;450)* 391 (168;662) 342 (163;548)**
Oxygen saturation (%) 9762.0 9661.9 9661.6
24 h Urinary volume (ml) 1731 (694;5008) 2068 (585;4356) 1812 (780;3945)
24 h Urinary sodium excretion (mmol) 156672 173692 174687
24 h Urinary protein excretion (g) 0.06 (0;0.12) 0.3 (0;9.4) 0.07 (0;0.17)
24 h Urinary albumin excretion (mg) 4.7 (0;23) 100 (1;6131) 10 (0;29)
24 h Urinary creatinine clearance (ml/min) 125 (83;213) 68 (14; 170) 115 (73;249)
Values are expressed as mean6SD, or as median (min; max) as appropriate. CKD= chronic kidney disease; AHT= arterial hypertension.
* p,0.05: control group versus CKD;
** p,0.05 AHT versus CKD.
doi:10.1371/journal.pone.0095895.t001
Renal Tissue Oxygenation in CKD and Hypertension
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medullary R2* levels between stage I–V of CKD (Figure 4 and
Figure S2 for results by gender).
In addition, within the CKD group no significant difference was
observed according to the renal diagnosis (Figure 5).
Changes in R2* after furosemide in hypertension or CKD
patients as compared with controls
The situation was different in acute conditions, since the
response to furosemide differed significantly between groups.
Medullary R2* but not cortical values decreased significantly
(suggesting an increase in medulla oxygenation) in the three
groups, both in men and women (Table 3) but the reduction was
significantly smaller in the CKD and AHT groups (Figure 6).
Although there was a trend towards larger furosemide-induced
decreases in medullary R2* in men, this difference was not
statistically significant. In age-and gender adjusted multivariable
linear regression analysis the furosemide-induced change in
medullary R2* (f-R2*) correlated significantly with eGFRmdrd
(adjusted b per ml/min/1.73 m2: 20.03 (95% CI 0.01; 0.05),
p = 0.003); the latter association persisted when intake of loop
diuretics was introduced in the model (see extended Methods and
Results S1).
The difference in furosemide-induced change between the AHT
and control group was not explained by a difference in eGFR. In
multivariate logistic regression adjusted for age, sex, and
eGFRmdrd, the furosemide-induced change in medullary change
in R2* level remained significantly smaller in the presence of AHT
(OR 0.81; 0.64–0.98, p = 0.047).
Associations between renal tissue R2* levels, CKD status,
hypertension, and kidney function
In multivariate logistic regression, adjusted for age, sex, body
mass index, hemoglobin, current smoking and urinary sodium
excretion, with CKD status as dichotomized dependent variable
(CKD compared with healthy controls and hypertensive subjects
pooled together), medullary R2* levels were not associated with
CKD status (OR(95% CI): 1.01 (0.86;1.18), p = 0.92). Medullary
R2* levels were also not associated with CKD status when
comparing the CKD group separately with healthy controls (CKD
vs controls, OR: 0.95 (0.79; 1.15), p = 0.59), or with the
hypertensive group (CKD vs. AHT, OR: 1.1 (0.91;1.35), p = 0.3).
Although cortical R2* levels were higher in CKD patients, this
difference was not statistically significant in adjusted models (CKD
versus non-CKD, OR: 1.20 (0.95; 1.51, p = 0.14)). The same trend
was seen when comparing the CKD group separately with healthy
controls (OR: 1.10 (0.85; 1.41), p = 0.49).
The determinants of renal cortical and medullary oxygenation
were also analyzed in the entire population using linear models.
There was no association between medullary R2* levels and eGFR
or any of the other predefined variables in the adjusted
multivariable linear regression analysis (Table 4A). No significant
difference was observed when antihypertensive treatment (renin-
angiotensin system (RAAS) blockers or antihypertensive treatment
in general) was added to the model. Similar results were found for
the association between medullary R2* values and creatinine
clearance as measured by 24 h urinary collection (adjusted b per
ml/min: 20.01, p= 0.96).
Results for cortical R2* levels and its associations with
predefined variables were also largely negative (Table 4A). There
was a positive association between gender and R2* levels (adjusted
Table 2. Drug treatment of participants.
CKD (n=95) AHT (n=58) Controls (n =42)
Antihypertensive medication (%)
Beta blocker 34.9 39.6 0
Alpha blocker 2.3 0 0
ACE-inhibitor 17.4 11.5 0
AT-II type 1 receptor blocker 52.3 26.4 0
Calcium channel blockers 32.6 35.9 0
Thiazide diuretic 27.9 20.8 0
Loop diuretic 17.4 3.9 0
Cholesterol lowering medication
Statine 57 33 5
Fibrate 1.2 0 0
Ezetimibe 5.8 9.6 0
Antiplatelet agent
Aspirin 31.4 41.5 2.4
Uric acid lowering medication
Allopurinol 17.4 3.9 0
Vitamin D 23.3 3.9 0
Antidiabetic medication
Oral antidiabetics 8.1 11.5 0
Insuline 17.4 3.8 0
All values are expressed as the percentage of patients of each group treated with the drug in question; CKD: chronic kidney disease (CKD), AHT: arterial hypertension
AHT.
doi:10.1371/journal.pone.0095895.t002
Renal Tissue Oxygenation in CKD and Hypertension
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b 21.8, p = 0.01). Hence, male participants had higher cortical
R2* levels, corresponding to lower cortical oxygenation.
Since only a small proportion of the variability in R2* levels was
explained by the predefined variables, some additional analyses
were performed on the entire population. Thus, a negative
correlation was found between medullary R2* levels and mean
arterial blood pressure (Table 4B). However, the correlation
between mean arterial pressure (MAP) and medullary R2* values
was weak and disappeared when including antihypertensive
treatment in the model (b 20.04 per mmHg, p= 0.043 before,
and b 20.03, p = 0.13 after adjustment for antihypertensive
treatment). Results of multivariable linear regression analysis are
shown in more detail in Table S2, S3, S4. Diabetic subjects
(n = 32) had higher cortical R2* values than non-diabetic subjects
(mean R2* 18.765.9 vs 17.561.6 sec21, p = 0.05), yet diabetes
was not associated with cortical oxygenation in adjusted logistic
regression models (Table S3). In contrast, cortical R2* levels
correlated positively and significantly with circulating glucose
levels as measured just before BOLD-MRI (Table 4B and Table
S4). Including antidiabetic treatments in the multivariate regres-
sion model did not alter this result.
The positive correlation found between uric acid and cortical
R2* levels did not change after the inclusion of allopurinol and
diuretic treatments, or mean arterial blood pressure in the model.
Results for cortical R2* levels stratified by sex are shown in
Table 5. Similar positive associations were found between cortical
R2* levels and uric acid; the association between cortical R2*
levels and glycemia were only present in men, whereas there was a
positive association between cortical R2* and age in women yet
not in men.
Figure 2. Probability density function (Kernel density) of renal R2* values. A/medullary R2* values and B/cortical R2* values.
doi:10.1371/journal.pone.0095895.g002
Renal Tissue Oxygenation in CKD and Hypertension
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Figure 3. Probability density function (Kernel density) of cortical R2* values by gender, according to group.
doi:10.1371/journal.pone.0095895.g003
Table 3. Baseline medullary and cortical R2*values and medullary cortical ratio’s (MCR), overall and by gender.
Control CKD AHT p (ANOVA)
Baseline Medullary R2* 29.3±2.4 28.8±2.6 28.6±2.1 0.44
men 29.562.7 29.162.6 28.762.1 0.53
women 29.061.7 28.362.7 28.462.2 0.50
Furosemide-induced Change medullary R2* 26.1±2.9 23.7±2.4 24.7±2.1 ,0.001
men 26.863.3 23.762.5 24.962.1 0.001
women 25.462.2 23.762.1 24.262.1 0.02
Baseline Cortical R2* 17.1 (15.9;18.7) 17.6 (16.5;18.6) 17.4 (16.3;18.3) 0.27
men 17.8 (16.9;19.0) 17.8 (17.0;18.5) 17.4 (16.4;18.2) 0.36
women 16.2 (15.3;17.8)* 17.5 (16.1;18.7) 17.4 (16.0;18.6) 0.18
Furosemide-induced Change cortical R2* 21.2 (20.83;21.52) 21.2 (20.58;21.8) 21.3 (20.86;21.92) 0.36
men 21.0 (20.88;22.2) 21.2 (20.55;21.8) 21.3 (21.0;21.78) 0.81
women 21.2 (20.52;21.5) 21.5 (20.59;22.0) 21.9 (20.9;22.4) 0.08
Baseline MCR ratio R2* 1.70±0.2 1.62±0.2 1.65±0.1 0.11
men 1.6460.2 1.6260.2 1.6660.1 0.71
women 1.7660.1 1.6360.16 1.6460.13 0.01
MCR ratio R2* after furosemide 1.44±0.2 1.51±0.2 1.50±0.1 0.21
men 1.3560.2 1.5160.2 1.4860.11 0.06
women 1.5460.2* 1.5260.1 1.5560.16 0.98
All values are shown before and after the administration of intravenous furosemide. Subjects on loop diuretics (n = 2 in the AHT group and n= 15 in the CKD group) are
not included in the furosemide-induced changes.
Values expressed in sec21, as mean6SD or as median (25th–75th percentile), as appropriate. CKD= chronic kidney disease; AHT = arterial hypertension. * P,0.05
concerning within-group differences between men and women.
doi:10.1371/journal.pone.0095895.t003
Renal Tissue Oxygenation in CKD and Hypertension
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In order to assess whether some of the results were linked to an
over-representation of young women in the control group,
sensitivity analyses were performed in a subgroup excluding
healthy women ,40 years (n = 13) and men aged .75 years
suffering from CKD (n= 5). The main results of the study
remained unchanged (see Methods and Results S1).
Discussion
The main findings of this study are that: 1) mean cortical and
medullary R2* values as a proxy for renal tissue oxygenation are
similar in hypertensive patients, CKD patients and healthy
controls; however, the distribution of cortical R2* values differs
markedly between groups, 2) the medullary R2* response to
furosemide is blunted in hypertensive patients and markedly
reduced in CKD patients, 3) baseline renal tissue oxygenation
appears to be remarkably stable over different degrees of kidney
dysfunction, independently of the cause of kidney disease and 4)
cortical R2* levels are positively associated with male gender,
glycemia and uric acid levels.
The first interesting observation of this paper is that although
mean cortical and medullary R2* look identical in hypertensive
and CKD patients and controls, the distribution of cortical R2*
differs between groups with a clear bimodal distribution in controls
and AHT and a unimodal shape of the distribution in CKD. As
found in our population, part of the bimodal distribution is linked
to the male/female ratio. However, this ratio is similar in
hypertensives and CKD patients suggesting other mechanisms
explaining the differences in distribution, which should be the
subject of further study.
The second finding of our study is that renal cortical and
medullary oxygenation as measured by BOLD-MRI appears to be
extremely well maintained in patients with CKD. Indeed, in
contrast to what has been observed experimentally we did not find
any decrease in cortical or medullary oxygenation even in
advanced CKD; the nature of the underlying renal disease does
not appear to play a major role. In this respect, our data are in
accordance with the study by Michaely et al [10], although the
latter study could be criticized for some methodological issues.
Despite the fact that our study has been performed under very
standardized hydration conditions, and detailed information was
available on possible confounders such as medication, sodium
intake and the type of underlying kidney disease we were not able
to demonstrate a reduction of tissue oxygenation as renal disease
progressed. In addition, this study also found no alterations in
renal R2* values in persons with essential hypertension in
comparison with healthy controls, despite the fact that numerous
previous animal studies have reported renal tissue hypoxia in AHT
[5].
The discrepancy between animal studies and BOLD-studies in
humans regarding oxygenation can be interpreted in different
ways. First of all, it might be that BOLD-MRI is not sensitive
enough or simply not as good a tool to assess renal tissue
oxygenation in CKD-patients as is direct invasive measurements
using microelectrodes. Nonetheless, early animal studies per-
formed to validate the BOLD-MRI technique have reported linear
Figure 5. Cortical and medullary R2* values according to the
cause of CKD. Values shown as boxplots; No (no CKD, n = 100), DM
(diabetic nephropathy, n = 20), AHT (hypertensive nephropathy, n = 31),
GN(glomerulonephritis, n = 17), reflux (reflux nephropathy, n = 6), one
(solitary kidney, n = 7), IF (interstitial nephritis, n = 6), other (other cause
of kidney disease, n = 8). There were no differences between cortical
and medullary R2* levels between the groups (ANOVA p= 0.10 and
p= 0.99, respectively)
doi:10.1371/journal.pone.0095895.g005
Figure 6. Furosemide-induced change in medullary R2* values
according to group.
doi:10.1371/journal.pone.0095895.g006
Figure 4. Medullary and cortical R2* values over decreasing
eGFRmdrd values. The number of subjects was n = 10 (for the eGFR.
125 ml/min/1.73 m2 category), 64 (eGFR 90–125), 65 (60–89), 36 (30–
59), 15 (15–29) and 5 (,15), respectively.
doi:10.1371/journal.pone.0095895.g004
Renal Tissue Oxygenation in CKD and Hypertension
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relationships between directly measured renal pO2 values and the
BOLD signal [22]. Alternatively, the ROI-technique used to
analyze BOLD-images might be less applicable in CKD patients,
where loss of cortico-medullary differentiation hampers manual
placement of ROIs. This might play a role in the interpretation of
medullary R2* values, but cortical R2* values are expected to be
reliable, thanks to its anatomic proximity with the kidney capsula.
Besides, the majority of subjects in the present study had less
advanced stage I–III kidney disease, and largely maintained
cortico-medullary differentiation; in patients with preserved
differentiation, BOLD-MRI is a reliable, reproducible method.
Nevertheless, it remains an open question if studies using different
methods of analysis such as the recently described compartmental
model [23] would obtain similar results. Assuming that BOLD-
MRI is able to correctly estimate tissue oxygenation in humans,
our findings together with those of Michaely et al put into question
whether ‘chronic renal hypoxia’ truly exists in humans. In
conditions of acute hypoxia, hypoxia-inducible factors (HIF) are
stabilized, which stimulates erythropoietin production, angiogen-
esis and metabolic reprogramming, offering protection and
increasing survival of renal tubular cells under hypoxic conditions
[2,24]. In contrast, chronic HIF stabilization stimulates interstitial
fibrosis, a process that is generally believed to compress
peritubular capillaries, which further decreases local tissue
oxygenation and leads to a vicious circle of HIF-stabilization,
increased formation of interstitial fibrosis, glomerulosclerosis and
renal function decline [3,25]. However, hypoxia-induced fibrosis
may not be a vicious circle that further worsens oxygenation, but
merely a way to maintain renal oxygenation by adapting oxygen
consumption to the demand. Identical mechanisms might operate
in animals. Animal models reporting hypoxia in CKD such as the
5/6 nephrectomy model may not have been carried out long
Table 4. Multivariate linear regression analysis examining correlations between baseline characteristics and medullary and cortical
R2* levels.
Medullary R2* Cortical R2*
A/ b1 P b1 p
Sex (female vs. male) 20.43 0.49 21.8 0.01
Age (per year) 20.01 0.72 20.01 0.7
BMI (per kg/m2) 20.03 0.61 20.04 0.58
eGFR (MDRD) 20.003 0.75 20.01 0.29
Smoking (yes vs. no) 0.28 0.77 1.04 0.16
Urinary 24 h sodium excretion (mmol) 0.002 0.52 0.004 0.13
Diabetes (yes vs. no) 21.01 0.41 1.67 0.07
B/ b1 P b1 p
Mean Arterial BP (per mmHg) 20.04 0.036 0.003 0.91
Urinary 24 h protein excretion (per g) 20.18 0.58 20.39 0.32
RAAS-blocker (yes vs.no) 20.86 0.11 0.34 0.6
Serum glycemia (per mmol/l) 20.11 0.54 0.91 ,0.001
Serum uric acid (per mmol/l) 20.0001 0.76 0.014 ,0.001
Correlations are expressed as regression coefficient b. Correlations between R2* levels and predefined factors are shown under (A). The analysis including the additional
variables glycemia, serum uric acid level and 24 h urinary proteinuria in the model is shown under (B).
1adjusted for gender, age, BMI, eGFR, smoking, urinary sodium excretion, Hemoglobin, and diabetes.
doi:10.1371/journal.pone.0095895.t004
Table 5. Multivariate linear regression analysis examining correlations between baseline characteristics and cortical R2* levels,
stratified by gender.
Cortical R2* Men Women
b6 p b6 p
Age (per year) 20.05 0.17 0.049 0.02
BMI (per kg/m2) 20.07 0.57 20.03 0.54
eGFR (MDRD) 20.03 0.11 20.002 0.81
Smoking (yes vs. no) 1.69 0.1 21.06 0.16
Urinary 24 h sodium excretion (mmol) 20.007 0.11 0.001 0.65
Diabetes (yes vs. no) 2.47 0.06 20.63 0.46
Glycemia (per mmol/l) 1.13 ,0.001 0.31 0.15
Uric acid (per mmol/l) 0.015 0.004 0.01 0.001
uadjusted for age, BMI, eGFR, smoking, urinary sodium excretion, Hb, and diabetes.
doi:10.1371/journal.pone.0095895.t005
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enough to simulate the long-term adaptive changes in the kidney
that might occur after several decades of chronic kidney disease or
hypertension in humans. In line with this hypothesis, Priardarshy
et al [26] evaluated renal oxygenation six to eight weeks after
remnant kidney creation (instead of the 2 weeks applied by
Manotham et al.)[1], and found that renal oxygenation was not
decreased, but rather increased in the remnant kidney. A similar
observation was made in renal artery stenosis with a reduction of
renal tissue oxygenation acutely but a good maintenance of tissue
oxygenation in the chronically stenotic kidney [14].
A role of renal handling of sodium in mediating oxygen
consumption is supported by our observation that the medullary
R2* response to furosemide differs between controls and
hypertensives with a blunted response in hypertension and an
even more marked reduction in CKD patients. In CKD, the
markedly reduced response to furosemide can be explained by the
reduced renal function leading to lower concentrations of
furosemide within the kidney. However, this cannot be the
explanation for hypertensive patients who had a comparable renal
function as controls. Pratt et al have previously demonstrated
ethnic differences in the response to furosemide [27]; to the best of
our knowledge, differences in response to furosemide between
normo-and hypertensive white subjects have not been reported
previously. The blunted response to furosemide observed in
hypertensive patients may be an indirect marker of the alterations
in renal sodium handling in hypertension. Persons with essential
hypertension have an increased proximal tubular reabsorption and
a reduced distal delivery of sodium, which might blunt the effect of
furosemide [28]. Alternatively, there might be differences in
mitochondrial metabolism and oxygen consumption in the thick
ascending limb of Henle between hypertensive and normotensive
subjects, in analogy with recently described differences between
Dahl salt-sensitive rats and salt-resistant control strains [29].
Our multivariate analysis enabled us to identify several new
factors associated with renal tissue oxygenation. Thus, cortical R2*
levels was positively and strongly associated with male gender. The
relationship with male gender was robust and persisted in
sensitivity analyses, and suggests that cortical oxygenation might
be regulated differently in men and women. It may also provide
some clues why renal function declines faster in men. However,
our data do not offer any explanation for the higher R2* values in
men, and studies measuring simultaneously renal perfusion and
tubular sodium handling are necessary to clarify this issue.
Renal tissue hypoxia has been a consistent finding in mouse and
rat models of diabetic nephropathy [4,30]. The reason why this
occurs is less certain, but oxydative stress and glomerular
hyperfiltration leading to increased tubular sodium load and
oxygen consumption have been proposed as the main mechanisms
[31,32]. BOLD-MRI studies in humans have shown mixed results,
some studies reporting higher, others lower R2* values in patients
with diabetes [8,9,33]. In this study, DM2 patients had slightly
higher cortical R2* levels than controls, suggesting lower tissue
oxygenation, yet this association was not maintained in adjusted
models. Interestingly, cortical oxygenation correlated linearly and
positively with glucose levels as measured just before the MRI
exam, suggesting that glycemia directly or indirectly (via sodium
transport) influences cortical oxygenation. In a study assessing the
influence of renin-angiotensin blockers on renal oxygenation in
patients with type 2 DM, we have recently reported similar results
[19]. These data suggest that episodes of hyperglycemia might
induce transient increases in oxygen consumption due to
hyperfiltration which increases sodium transport in the proximal
tubule [34]. The pre-MRI glycemia has not been systematically
reported in previous studies, which might partly explain previous
mixed results. The herein described association offers an
alternative explanation in humans for to the relationship between
badly controlled diabetes mellitus and adverse renal outcome [35].
However, the described relationship is based on a cross-sectional
analysis which limits causal inferences, and needs confirmation in
interventional studies.
Our observation that circulating uric acid levels correlate
positively with cortical R2* levels adds information to the ongoing
debate about the role of uric acid in cardiovascular disease.
Hyperuricemia-induced cortical vasoconstriction could be partly
responsible for the herein described correlation between uric acid
and cortical hypoxia [36], but more studies are necessary to clarify
this.
This study has some limitations. Firstly, no information was
acquired on renal perfusion. We therefore cannot determine
whether changes in oxygenation were the result of alterations in
oxygen delivery. Nevertheless, Textor and colleagues have shown
previously that renal tissue oxygenation is largely independent of
renal blood flow, and that cortical (but not medullary) oxygenation
only falls in case of severe renal artery stenosis occluding more
than 90% of the lumen [13]. Another limitation of our study is its
cross-sectional design. Finally, all measurements were performed
without stopping concomitant medication, which might have
weakened eventual underlying differences in R2* levels between
the groups
Conclusion
Our data suggest that renal tissue oxygenation at rest is
comparable in controls, treated hypertensives and CKD patients.
However, the response to furosemide differs between groups
providing some insights on the mechanisms linking renal tubular
function, oxygen consumption and renal function in hypertension
and/or chronic kidney diseases. Our data do not support the
concept that chronic kidney disease is associated with decreased
renal tissue oxygenation in humans, as repeated observed in
animal models. However, acute changes in oxygenation most
likely occur in humans, as illustrated by the changes in R2* in
response to furosemide. Future interventional studies should clarify
the role of renal sodium handling, blood glucose and serum uric
acid in the regulation of renal tissue oxygenation as newly
described in this study. The differences in cortical R2* levels
between men and women suggest that renal oxygenation is
possibly regulated differently in men and women; this point also
needs further study. Although no correlation was found between
R2* values and (previous) kidney function, it is still possible that
renal tissue R2* values predict kidney function decline but this is to
be demonstrated in prospective studies.
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